SCHEMBL7153134

SCHEMBL7153134

Cc1c(Cl)ccc2cc(Cl)ccc12

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.43
TP53 P04637 3/20 0.42
POLB P06746 1/20 0.41
NR4A2 P43354 1/20 0.39
TSHR P16473 2/20 0.38
CYP3A4 P08684 2/20 0.38
ALDH1A1 P00352 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
MAPT P10636 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.36
MCL1 Q07820 1/20 0.36
TYMS P04818 1/20 0.36
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
AHR P35869 1/20 0.35
RAPGEF4 Q8WZA2 1/20 0.35
LMNA P02545 1/20 0.35
F11 P03951 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6561368 0.78 CYP2A6 (0.57) CYP2A6TP53POLBNR4A2TSHR
SCHEMBL9244984 0.77 CYP2A6 (0.54) CYP2A6TP53NR4A2TSHRCYP3A4
SCHEMBL2171080 0.76 CYP1A2 (0.48) CYP2A6TP53ALDH1A1HSD17B10MAPT
SCHEMBL12205409 0.76 CYP2A6 (0.55) CYP2A6TP53POLBNR4A2TSHR
Hydrochloric Acid SCHEMBL29200220 0.76 CYP2A6 (0.52) CYP2A6TP53NR4A2TSHRCYP3A4
SCHEMBL2723074 0.76 CYP2A6 (0.52) CYP2A6TP53POLBNR4A2CYP3A4
SCHEMBL18517084 0.75 CYP2A6 (0.50) CYP2A6POLBNR4A2TSHRCYP3A4
SCHEMBL11057827 0.74 POLB (0.46) CYP2A6TP53POLBNR4A2CYP3A4
SCHEMBL3862631 0.74 TSHR (0.48) CYP2A6TP53TSHRCYP3A4ALDH1A1
SCHEMBL3891844 0.73 CYP2A6 (0.60) CYP2A6TSHRCYP3A4ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6632916-B2 Conductive polymer having a phenylene vinylene backbone with a condensed hydrocarbon ring system introduced into the backbone to form a bend in a linear structure of the phenylene vinylene backbone. TOYODA GOSEI CO., LTD. (JP) 2003-10-14 US disclosed
US-20030092878-A1 Composite type conductive polymer and process of producing aromatic compound TOYODA GOSEI CO., LTD. (JP) 2003-05-15 US disclosed
EP-1267359-A2 Composite type electroconductive polymer and process of producing an aromatic compound Toyoda Gosei Co., Ltd. (JP) 2002-12-18 EP disclosed
US-5876865-A POLYARYLENEVINYLENE RESIN XEROX CORPORATION (US) 1999-03-02 US disclosed
US-5817430-A POLYARYLENEVINYLENE POLYMER XEROX CORPORATION (US) 1998-10-06 US disclosed
US-4919848-A Process for the quenching of fluorescence, and new cationic naphthalene-peri-dicarboxylic acid imide derivatives BAYER AKTIENGESELLSCHAFT (DE) 1990-04-24 US disclosed
US-4695405-A Process for quenching fluorescence, and new cationic or amphoteric aromatic nitro compounds BAYER AKTIENGESELLSCHAFT (DE) 1987-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030092878-A1 Composite type conductive polymer and process of producing aromatic compound KCNH1, PIEZO1, KCNH3 CYP2A6 2875/4885TP53 4657/4885POLB 974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.